Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | SOD1 | P00441 | 1/20 | 0.43 |
| ▸ | HMGCR | P04035 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3398362 | 0.97 | SOD1 (0.43) | POLBMEN1GAAKMT2AACHE | |
| SCHEMBL1786941 | 0.87 | SOD1 (0.45) | POLBGAAACHESOD1LMNA | |
| SCHEMBL22928234 | 0.85 | CCNT1 (0.43) | POLBACHESOD1HMGCRLMNA | |
| SCHEMBL7772917 | 0.85 | MEN1 (0.54) | POLBMEN1GAAKMT2AACHE | |
| SCHEMBL3396886 | 0.82 | L3MBTL1 (0.45) | POLBGAAACHESOD1LMNA | |
| SCHEMBL3400425 | 0.82 | SOD1 (0.42) | POLBGAAACHESOD1LMNA | |
| SCHEMBL1787920 | 0.82 | L3MBTL1 (0.45) | POLBGAAACHESOD1LMNA | |
| SCHEMBL1787386 | 0.82 | SOD1 (0.42) | POLBGAAACHESOD1LMNA | |
| SCHEMBL1790783 | 0.80 | CA1 (0.57) | POLBMEN1GAAKMT2AACHE | |
| SCHEMBL20710757 | 0.80 | L3MBTL1 (0.49) | MEN1GAAKMT2AACHECA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210024498-A1 | TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF | MEDICONNS SHANGHAI BIOPHARMACEUTICAL CO LTD (CN) | 2021-01-28 | — | — | US | disclosed |
| EP-2249426-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEM CORP (JP) | 2019-07-10 | — | — | EP | disclosed |
| CN-105762402-A | Nonaqueous electrolyte solution and nonaqueous electrolyte battery | 三菱化学株式会社 | 2016-07-13 | — | — | CN | disclosed |
| CN-103078137-B | Nonaqueous electrolyte solution and nonaqueous electrolyte battery | MITSUBISHI CHEMICAL CORP. (JP) | 2015-09-16 | — | — | CN | disclosed |
| US-9083058-B2 | Nonaqueous electrolytic solution and nonaqueous-electrolyte battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-07-14 | — | — | US | disclosed |
| CN-104600360-A | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEM CORP | 2015-05-06 | — | — | CN | disclosed |
| US-8916298-B2 | Nonaqueous electrolytic solution and nonaqueous-electrolyte battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-12-23 | — | — | US | disclosed |
| US-8889302-B2 | Nonaqueous electrolytic solution and nonaqueous-electrolyte battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-11-18 | — | — | US | disclosed |
| US-8846254-B2 | — | — | 2014-09-30 | — | — | US | disclosed |
| US-20140134481-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-05-15 | — | — | US | disclosed |
| CN-103078137-A | Nonaqueous electrolyte solution and nonaqueous electrolyte battery | MITSUBISHI CHEM CORP | 2013-05-01 | — | — | CN | disclosed |
| US-20120308883-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-12-06 | — | — | US | disclosed |
| US-20120219854-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-08-30 | — | — | US | disclosed |
| US-20110123871-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY | MITSUBISHI CHEMCIAL (JP) | 2011-05-26 | — | — | US | disclosed |
| CN-101960662-A | Nonaqueous electrolyte solution and nonaqueous electrolyte battery | MITSUBISHI CHEM CORP | 2011-01-26 | — | — | CN | disclosed |
| EP-2249426-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | Mitsubishi Chemical Corporation (JP) | 2010-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210024498-A1 | TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF | PRLHR, DRD2, AVPR2 | POLB 4601/4885MEN1 2812/4885GAA 2887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.